Amarin Corporation plcAMRN was a big mover last session, as the company saw its shares rise almost 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company since May 12, as the stock is now up almost 37%.
In the last 30 days, the company has seen one downward estimate revision and the Zacks Consensus Estimate also moved lower, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Amarin currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked Bio-medical/Gene stock is ANI Pharmaceuticals, Inc. ANIP , which sports a Zacks Rank #1 (Strong Buy).
Is AMRN going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMARIN CORP PLC (AMRN): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
